Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
| Image |  |
|---|---|
| Description | scientific article published on 18 September 2017 |
| Author/s |
author: Sebastian Bauer Maria Debiec-Rychter Agnieszka Wozniak Jean-Yves Blay Piotr Rutkowski Silvia Stacchiotti |
| Publication date | September 18, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |